All In Biotech

Free tool

FAERS Monitor: Remeron

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020415 or its brand name (Remeron, Mirtazapine). Reports on generic versions are filed under their own applications.

Reports

93,069

Serious

77,961

84% of reports

Hospitalization

38,021

Death reported

14,287

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea5,124
  • fatigue5,006
  • drug ineffective4,903
  • fall4,248
  • diarrhoea4,175
  • off label use4,082
  • toxicity to various agents3,985
  • dizziness3,670
  • anxiety3,652
  • dyspnoea3,602
  • death3,521
  • drug interaction3,468
  • vomiting3,362
  • depression3,346
  • headache3,238

Reports by year received

View as table
YearReports
20041,058
20051,207
20061,307
20071,300
20081,305
20091,892
20102,234
20112,590
20122,748
20132,527
20143,087
20154,008
20164,596
20175,114
20186,608
20197,303
20207,212
20216,131
20226,330
20236,409
20246,273
20256,720
20265,107

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,961,090 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
toxicity to various agentsSignal3,9855.45.314,229
drug interactionSignal3,4685.04.911,026
depressionSignal3,3463.43.25,516
anxietySignal3,6522.92.84,627
fallSignal4,2482.92.85,336
dizziness3,6701.71.6997
vomiting3,3621.61.6810
nausea5,1241.51.4783
diarrhoea4,1751.51.4630
fatigue5,0061.51.4737
dyspnoea3,6021.41.4496
headache3,2381.21.180
off label use4,0821.11.012
death3,5210.90.923
drug ineffective4,9030.80.8158

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.